Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_4

Forced Fluid Removal in High Risk Acute Kidney Injury

NCT02458157
completednot_applicable

The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock

NCT02566460
completednot_applicable

Resuscitation of Late-preterm Infants by Using Room Air or 100% Oxygen

NCT01305031
completedphase_3

Oxygen Toxicity in the Resuscitation in Extremely Premature Infants

NCT00494702

Clinical Trials (4)

Showing 4 of 4 trials
NCT02458157Phase 4

Forced Fluid Removal in High Risk Acute Kidney Injury

Terminated
NCT02566460Not Applicable

The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock

Completed
NCT01305031Not Applicable

Resuscitation of Late-preterm Infants by Using Room Air or 100% Oxygen

Completed
NCT00494702Phase 3

Oxygen Toxicity in the Resuscitation in Extremely Premature Infants

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4